Mycoplasma detection by NAT: an overview on Validation and Health Authorities requirements
Posted on February 26, 2013
By: Emiliano Toso, Head of the Molecular Biology; Fabio La Neve, Associate Scientist; Fabrizio Lecce , Associate Scientist; Federica Gillone , Associate Scientist.
Merck Serono
Mycoplasma Mycoplasma Detection in Biopharmaceutical Production Mycoplasma are a critical problem for biomedical research laboratories and biopharmaceutical companies that use cell cultures in the development and manufacturing of biological and biopharmaceutical products for therapeutic use, such...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Culture Method, Indicator Cell Culture Method, Limit of Detection (LOD), monoclonal antibody, Mycoplasma, Mycoplasma Detection, Nucleic Acid Amplification techniques (NAT), vaccines
Related Products
MycoSEQ™ Mycoplasma Detection Assay - Life TechnologiesSubscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
